Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma - PubMed (original) (raw)

Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma

Nadine M Vaninetti et al. Mol Carcinog. 2008 Apr.

Abstract

Nitric oxide (NO) has been implicated as a potential causative factor for endogenous p53 mutations in gastrointestinal malignancy. To investigate the role of NO in esophageal adenocarcinoma (EADC), we studied patterns of p53 mutations, expression of inducible nitric oxide synthase (iNOS) and the tissue accumulation of nitrotyrosine (NTS), a stable reaction product of NO and a marker for cellular protein damage, in human premalignant and malignant esophageal epithelia. Tissues were obtained from patients with gastroesophageal reflux disease (GERD)-induced esophagitis (n = 76), Barrett's esophagus (BE; n = 119) and primary EADC (n = 54). DNA sequencing was used to characterize p53 mutations, RT-PCR to study iNOS mRNA expression, and immunohistochemistry to study NTS. Relative to self-matched normal epithelia, a progressive increase in iNOS mRNA expression was seen in GERD (30%; 23/76), BE (48%; 57/119), and EADC (63%; 34/54) tissues (P < 0.001). Among patients with EADC, elevated levels of NTS immunoreactivity were more frequent in tumors with p53 mutations (11/21; 52%) compared with tumors with wild-type p53 (9/33; 27%; P = 0.063), and specifically in tumors with p53 mutations at CpG dinucleotides (10/12; 83%) compared with non-CpG p53 mutations (1/9; 11%; P = 0.008). The increasing frequency of iNOS (mRNA) overexpression in GERD, BE and EADC supports the hypothesis that an active inflammatory process, most likely a consequence of GERD, underlies molecular progression to EADC. The highly significant association between NTS, reflecting chronic NO-induced cellular protein damage, and endogenous p53 mutations at CpG dinucleotides, provides further evidence for a molecular link between chronic inflammation and esophageal malignancy.

PubMed Disclaimer

Cited by

Carcinogen 4-Nitroquinoline Oxide (4-NQO) Induces Oncostatin-M (OSM) in Esophageal Cells.
Mukherjee A, Epperly MW, Fisher R, Shields D, Hou W, Pennathur A, Luketich J, Wang H, Greenberger JS. Mukherjee A, et al. In Vivo. 2023 Mar-Apr;37(2):506-518. doi: 10.21873/invivo.13108. In Vivo. 2023. PMID: 36881075 Free PMC article.
Recognizing Pattern and Rule of Mutation Signatures Corresponding to Cancer Types.
Chen L, Zhou X, Zeng T, Pan X, Zhang YH, Huang T, Fang Z, Cai YD. Chen L, et al. Front Cell Dev Biol. 2021 Aug 26;9:712931. doi: 10.3389/fcell.2021.712931. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34513841 Free PMC article.
Non-surgical animal model of gastroesophageal reflux disease by overeating induced in mice.
Im NR, Kim B, Jung KY, Kim TH, Baek SK. Im NR, et al. J Investig Med. 2021 Aug;69(6):1208-1214. doi: 10.1136/jim-2020-001691. Epub 2021 Apr 16. J Investig Med. 2021. PMID: 33863754 Free PMC article.
DNA Methylation-a Potential Source of Mitochondria DNA Base Mismatch in the Development of Diabetic Retinopathy.
Mishra M, Kowluru RA. Mishra M, et al. Mol Neurobiol. 2019 Jan;56(1):88-101. doi: 10.1007/s12035-018-1086-9. Epub 2018 Apr 21. Mol Neurobiol. 2019. PMID: 29679259
Oesophageal cancer.
Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D. Smyth EC, et al. Nat Rev Dis Primers. 2017 Jul 27;3:17048. doi: 10.1038/nrdp.2017.48. Nat Rev Dis Primers. 2017. PMID: 28748917 Free PMC article. Review.

Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma - PubMed (original) (raw)